Bone Marrow Biopsy
Diagnosis:
- Slightly hypercellular marrow (70%) w/ trilineage hematopoiesis
- Megakaryocitic hyperplasia
- Plasma cell dyscrasia (1% plasma cells by immunihistochemistry, monoclonal lambda by FCM)
Seg neutrophils 54%
Lymphocytes 34%
Monocytes 10%
Eos 2%
Number & Morphologies of Erythrocytes and Leukocytes: normal or within normal limits
Number & Morphology of Platelets: normal or within normal limits
Aspirate: Diff (500 cells)
Myeloblast 1.0 (0.1 - 1.7) Pro 1.0 (0.1 - 1.1)
Promyelo 3.2 (1.9 - 4.7) Baso 3.2 (0.4 - 2.4)
Myelo 17.0 (8.5 - 16.9) Poly 21.2 (13.1 - 30.1)
Meta 9.0 (7.1 - 24.7) Ortho 7.2 (0.3 - 3.7)
Band 11.2 (9.4 - 15.4) Megs 0.6 (0.1 - 0.4)
Seg 13.4 (3.8 - 11.0) Mono 0.6 (0.0 - 0.6)
Eos 11.4 (1.1 - 5.2) Plasma 0.0 (0.0 - 3.5)
Baso 0.0 (0.0 - 0.2) Lympho 0.0 (8.6 - 23.8)
Other 0.0 Lymphoblasts 0.0
M:E ratio 2.0
Specimen quality: adequate
M:E maturation: normal
Megakaryocytic Morphology: increased w/ occasional small hypolobate forms
Special Stains
Storage Iron: adequate
Sideroblastic Iron: adequate
Ring Sideroblasts: absent
Core Biopsy: Bone Trebeculae: normal
Cellularity: 70%
Trilineage Hematopoiesis
Megakaryocyte: increased, occasional small hypolobate forms and loose clustering
Special Stains/Immunohistochemical Stains
Reticulin Stain: no increase in fibrosis
CD138: Positive in 1% of nucleated cells
Particle Clot: similar to core biopsy
FCM: Specimen: bone marrow aspirate
Interpretation: Abnormal plasma cells CD38++,CD19-, CD20+, CD45-, CD56-, expressing cytoplasmic lambda light chains, normal plasma cells not detected. phenotypically normal myeloid cells w/o evidence of T-cell lymphoproliferative disorder or acute leukemia.
CBC:
WBC: 6.84 K/MCL
RBC: 5.61 M/MCL
HGB: 16.6 G/DL
HCT: 48.4%
MCV: 86.3 FL
MCH: 29.6 PG
MCHC: 34.3 G/DL
RDW: 12.3%
PLT: 307 K/MCL
Differential:
Granulocyte # (%): 3.99 k/uL (58.4)
Eos # (%): 0.24 k/uL (3.5)
Baso # (%): 0.07 k/uL (1.0)
Mono # (%): 0.73 k/uL (10.7)
Lympho # (%): 1.78 k/uL (26.0)
IG # (%): 0.12 k/uL H (1.4H)
Nucleated RBC # (%): < 10 (0.0) normal value: not detected
Gross Description: Specimen taken from right posterior iliac crest.
Now the Phenotyping test.
Your Markers: total 22, CD2(80%), CD3(73%), CD4(42%), CD5(75%), CD7(71%), CD8(26%), CD16(9%), CD56(7%), CD10(4%), CD19(15%), CD20(16%), Kappa(5%), Lambda(5%), Cyto K(See Note), Cyto L(See Note), CD34(<1%), CD11b(4%), CD13(2%), CD33(4%), CD64(2%), CD38(see Note), CD45(see Note)
Analysis: FCM of bone marrow aspirate: 7% of CD45+ leukocytes are lymphcytes, 3% are monocytes, and 90% are myeloid cells. 73% of lymphocytes are T-cells, 9% are NK cells, and 16% are B-cells. T-cells appear phenotypically normal, CD4:CD8 ratio 1.6. 25% of CD19+ B-cells express CD10, variable CD20, but lack surface light chains and are consistent w/ hematogones. Mature B-cells have normal intensity CD20, polytypic, w/ K:L ratio 1.0. Abnormal plasma cells expressing bright CD38, monotypic cytoplasmic lambda light chains, CD19-, CD20+, CD45-, CD56-. Myeloid cells demonstrate phenotypically normal expression patterns for markers evaluated. 1% CD34 positive myeloblasts. Specimen viability: 93%
I know this a lot of info. I was initially evaluated for a myeloproliferative neoplasm (polycythemia vera). I am a 40 year old male and I have had a lot of excruciating bone pain, intermittently abnormal CBC and CMP tests for over 5 years now.
Like I said originally, I was referred to this doc because my RBC, HCT, and HGB kept going to high. My doc discounted both of these tests, saying they were normal and not to worry about them, but when I read through the reports after I asked for copies, I became a little worried about the plasma cell dyscrasia diagnosis of malignancy. My grandfather died of multiple myeloma, so the reports kinda hit a nerve.
I found this site while doing research and it has answered a lot of questions, but I still have a ton more. Right now I am wondering if any of this stands out or should have prompted my doc to say more than, "don't worry about them. The results are normal for someone your age."